GGrantIndex
Sort

21,453 grants matching tuberculosis

Stellenbosch University Clinical Trials Unit (SUN-CTU)

$2,276,671
Mark Fredric Cotton · Stellenbosch University · UM1 · FY2020 · AI

Immunopathogenic Mechanisms of Human Immunodeficiency Virus (HIV) Disease

$2,275,272
Irini Sereti · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI

The Military HIV Research Program (MHRP) Clinical Trial Unit

$2,272,671
Merlin L Robb · Henry M. Jackson Fdn For The Adv Mil/Med · UM1 · FY2021 · AI

Safety Evaluation of Anti-Infective Agents

$2,272,188
Jon Carl Mirsalis · Sri International · N01 · FY2011 · AI

Systems Genetics of Tuberculosis

$2,271,183
Christopher M Sassetti · Univ Of Massachusetts Med Sch Worcester · P01 · FY2018 · AI

Resistance to MTB infection in HIV infected individuals in Uganda and S. Africa

$2,270,572
W. Henry Henry Boom · Case Western Reserve University · R01 · FY2019 · AI

IMMUNE MECHANISMS CONTROLLING INFLAMMATION AND CANCER

$2,270,149
Dartmouth College · P20 · FY2002 · RR

Administrative Core

$2,264,304
David Louis Horn · Rbhs-New Jersey Medical School · U19 · FY2020 · AI

Human monoclonal antibodies targeting infectious pathogens

$2,263,771
Joshua Tan · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI

The Johns Hopkins University - Uganda Clinical Trials Unit

$2,263,627
Mary Glenn Fowler · Johns Hopkins University · UM1 · FY2023 · AI

THE SOUTHWEST NATIONAL PRIMATE RESEARCH CENTER

$2,260,961
Kenneth Parkhurst Trevett · Texas Biomedical Research Institute · P51 · FY2009 · RR

The Southwest National Primate Research Center: Rhesus Macaque Expansion

$2,256,688
Larry S. Schlesinger · Texas Biomedical Research Institute · P51 · FY2022 · OD

IeDEA Asia-Pacific Research Collaboration

$2,253,765
Annette H Sohn · Foundation For Aids Research · U01 · FY2019 · AI

East Africa IeDEA Regional Consortium

$2,253,031
Kara Kay Wools-Kaloustian · Indiana University Indianapolis · U01 · FY2014 · AI

Molecular Mechanisms of Pathogenesis of Acute and Chronic Liver Diseases

$2,252,657
Patrizia Farci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI

Center for Lung Biology and Disease

$2,251,189
Samithamby Jeyaseelan · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2020 · GM

ADULT THERAPEUTIC CLINICAL TRIALS PROGRAM FOR AIDS

$2,250,354
University Of North Carolina Chapel Hill · U01 · FY2000 · AI

MIDAS Center for Communicable Disease Dynamics

$2,249,976
Marc Lipsitch · Harvard School Of Public Health · U54 · FY2017 · GM

MIDAS Center for Communicable Disease Dynamics

$2,249,976
Marc Lipsitch · Harvard School Of Public Health · U54 · FY2016 · GM

MIDAS Center for Communicable Disease Dynamics

$2,249,976
Marc Lipsitch · Harvard School Of Public Health · U54 · FY2018 · GM

New potent orally bioavailable nitro-containing compounds to treat mycobacterial infections

$2,248,740
Robert B Abramovitch · Michigan State University · R01 · FY2025 · AI

MICROBIOLOGY AND INFECTIOUS DISEASES BIOLOGICAL RESOURCE REPOSITORY (MID-BRR)

$2,248,430
Timothy T Stedman · American Type Culture Collection · N01 · FY2013 · AI

Kaiser Washington Vaccine and Treatment Evaluation Unit

$2,248,353
Lisa A Jackson · Kaiser Foundation Research Institute · UM1 · FY2022 · AI

Center for Lung Biology and Disease

$2,246,019
Samithamby Jeyaseelan · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2021 · GM

TUBERCULOSIS ELIMINATION AND LABORATORY FUNDING ANNOUNCEMENT

$2,243,573
Connie Calisti-Myers · New Jersey State Dept/Health/Senior Srvs · U52 · FY2015 · PS